ACC/AHA
Guideline Update for Perioperative Cardiovascular
Evaluation for Noncardiac Surgery
A
Report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines
(Committee to Update the 1996 Guidelines on Perioperative
Cardiovascular Evaluation for Noncardiac Surgery)
References
1.
Mangano DT. Perioperative cardiac morbidity. Anesthesiology.
1990;72:153-84.
3.
Fleisher LA, Beattie C. Current practice in the
preoperative evaluation of patients undergoing
major vascular surgery: a survey of cardiovascular
anesthesiologists. J Cardiothorac Vasc Anesth.
1993;7:650-4.
4.
Wells PH, Kaplan JA. Optimal management of patients
with ischemic heart disease for noncardiac surgery
by complementary anesthesiologist and cardiologist
interaction. Am Heart J. 1981;102:1029-37.
5.
Roger VL, Ballard DJ, Hallett JW Jr, Osmundson
PJ, Puetz PA, Gersh BJ. Influence of coronary
artery disease on morbidity and mortality after
abdominal aortic aneurysmectomy: a population-based
study, 1971-1987. J Am Coll Cardiol. 1989;14:1245-52.
6.
Hertzer NR. Basic data concerning associated coronary
disease in peripheral vascular patients. Ann Vasc
Surg. 1987;1:616-20.
7.
Hlatky MA, Boineau RE, Higginbotham MB, et al.
A brief self-administered questionnaire to determine
functional capacity (the Duke Activity Status
Index). Am J Cardiol. 1989;64:651-4.
8.
Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation
and management of patients with both peripheral
vascular and coronary artery disease. J Am Coll
Cardiol. 1991;18:203-14.
9.
Jamieson WRE, Janusz MT, Miyagishima RT, Gerein
AN. Influence of ischemic heart disease on early
and late mortality after surgery for peripheral
occlusive vascular disease. Circulation. 1982;66(suppl
1):I-92-97.
10.
Ewy GA. The abdominojugular test: technique and
hemodynamic correlates. Ann Intern Med. 1988;109:456-60.
11.
Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E.
Bedside cardiovascular examination in patients
with severe chronic heart failure: importance
of rest or inducible jugular venous distension.
J Am Coll Cardiol. 1993;22:968-74.
12.
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial
index of cardiac risk in noncardiac surgical procedures.
N Engl J Med. 1977;297:845-50.
13.
Dajani AS, Bisno AL, Chung KJ, et al. Prevention
of bacterial endocarditis: recommendations by
the American Heart Association. JAMA. 1990;264:2919-22.
14.
Nelson AH, Fleisher LA, Rosenbaum SH. Relationship
between postoperative anemia and cardiac morbidity
in high-risk vascular patients in the intensive
care unit. Crit Care Med. 1993;21:860-6.
15.
Ashton CM, Petersen NJ, Wray NP, et al. The incidence
of perioperative myocardial infarction in men
undergoing noncardiac surgery. Ann Intern Med.
1993;118:504-10.
16.
Hollenberg M, Mangano DT, Browner WS, London MJ,
Tubau JF, Tateo IM. Predictors of postoperative
myocardial ischemia in patients undergoing noncardiac
surgery: The Study of Perioperative Ischemia Research
Group. JAMA. 1992;268:205-9.
17.
Hubbard BL, Gibbons RJ, Lapeyre AC III, Zinsmeister
AR, Clements IP. Identification of severe coronary
artery disease using simple clinical parameters.
Arch Intern Med. 1992;152:309-12.
18.
Lette J, Waters D, Bernier H, et al. Preoperative
and long-term cardiac risk assessment: predictive
value of 23 clinical descriptors, 7 multivariate
scoring systems, and quantitative dipyridamole
imaging in 360 patients. Ann Surg. 1992;216:192-204.
19.
Mangano DT, Browner WS, Hollenberg M, London MJ,
Tubau JF, Tateo IM. Association of perioperative
myocardial ischemia with cardiac morbidity and
mortality in men undergoing noncardiac surgery:
The Study of Perioperative Ischemia Research Group.
N Engl J Med. 1990;323:1781-8.
20.
Michel LA, Jamart J, Bradpiece HA, Malt RA. Prediction
of risk in noncardiac operations after cardiac
operations. J Thorac Cardiovasc Surg. 1990;100:595-605.
21.
Eagle KA, Coley CM, Newell JB, et al. Combining
clinical and thallium data optimizes preoperative
assessment of cardiac risk before major vascular
surgery. Ann Intern Med. 1989;110:859-66.
22. Detsky AS, Abrams HB, McLaughlin
JR, et al. Predicting cardiac complications in
patients undergoing non-cardiac surgery. J Gen
Intern Med. 1986;1:211-9.
23.
Foster ED, Davis KB, Carpenter JA, Abele S, Fray
D. Risk of noncardiac operation in patients with
defined coronary disease: The Coronary Artery
Surgery Study (CASS) registry experience. Ann
Thorac Surg. 1986;41:42-50.
24.
Cooperman M, Pflug B, Martin EW Jr, Evans WE.
Cardiovascular risk factors in patients with peripheral
vascular disease. Surgery. 1978;84:505-9.
25.
Tarhan S, Moffitt EA, Taylor WF, Giuliani ER.
Myocardial infarction after general anesthesia.
JAMA. 1972;220:1451-4.
26.
Gunnar RM, Passamani ER, Bourdillon PD, et al.
Guidelines for the early management of patients
with acute myocardial infarction: a report of
the American College of Cardiology/American Heart
Association Task Force on Assessment of Diagnostic
and Therapeutic Cardiovascular Procedures (Subcommittee
to Develop Guidelines for the Early Management
of Patients with Acute Myocardial Infarction).
J Am Coll Cardiol. 1990;16:249-92.
27.
Fletcher GF, Balady G, Froelicher VF, Hartley
LH, Haskell WL, Pollock ML. Exercise standards:
a statement for healthcare professionals from
the American Heart Association: Writing Group.
Circulation. 1995;91:580-615.
28.
Steen PA, Tinker JH, Tarhan S. Myocardial reinfarction
after anesthesia and surgery. JAMA. 1978;239:2566-70.
29.
Rao TL, Jacobs KH, El-Etr AA. Reinfarction following
anesthesia in patients with myocardial infarction.
Anesthesiology. 1983;59:499-505.
30.
Hertzer NR. Fatal myocardial infarction following
peripheral vascular operations: a study of 951
patients followed 6 to 11 years postoperatively.
Cleve Clin Q. 1982;49:1-11.
31.
Mahar LJ, Steen PA, Tinker JH, Vlietstra RE, Smith
HC, Pluth JR. Perioperative myocardial infarction
in patients with coronary artery disease with
and without aorta/-coronary artery bypass grafts.
J Thorac Cardiovasc Surg. 1978;76:533-7.
32.
Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic
importance of a clinical profile and exercise
test in medically treated patients with coronary
artery disease. J Am Coll Cardiol. 1984;3:772-9.
33.
Nelson CL, Herndon JE, Mark DB, Pryor DB, Califf
RM, Hlatky MA. Relation of clinical and angiographic
factors to functional capacity as measured by
the Duke Activity Status Index. Am J Cardiol.
1991;68:973-5.
34.
Myers J, Do D, Herbert W, Ribisl P, Froelicher
VF. A nomogram to predict exercise capacity from
a specific activity questionnaire and clinical
data. Am J Cardiol. 1994;73:591-6.
35.
Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh
BJ. Long-term survival in patients with coronary
artery disease: importance of peripheral vascular
disease. The Coronary Artery Surgery Study (CASS)
Investigators. J Am Coll Cardiol. 1994;23:1091-95.
36.
Guidelines for coronary angiography: a report
of the American College of Cardiology/American
Heart Association Task Force on Assessment of
Diagnostic and Therapeutic Cardiovascular Procedures
(Subcommittee on Coronary Angiography). J Am Coll
Cardiol. 1987;10:935-50.
37.
Morris CK, Ueshima K, Kawaguchi T, Hideg A, Froelicher
VF. The prognostic value of exercise capacity:
a review of the literature. Am Heart J. 1991;122:1423-31.
38.
Chaitman BR. The changing role of the exercise
electrocardiogram as a diagnostic and prognostic
test for chronic ischemic heart disease. J Am
Coll Cardiol. 1986;8:1195-210.
39.
Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced
ST depression in the diagnosis of coronary artery
disease: a meta-analysis. Circulation. 1989;80:87-98.
40.
Detrano R, Gianrossi R, Mulvihill D, et al. Exercise-induced
ST segment depression in the diagnosis of multivessel
coronary disease: a meta analysis. J Am Coll Cardiol.
1989;14:1501-8.
41.
Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf
RM, Pryor DB. Exercise treadmill score for predicting
prognosis in coronary artery disease. Ann Intern
Med. 1987;106:793-800.
42.
Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic
value of a treadmill exercise score in outpatients
with suspected coronary artery disease. N Engl
J Med. 1991;325:849-53.
43.
Guidelines for exercise testing: a report of the
American College of Cardiology/American Heart
Association Task Force on Assessment of Cardiovascular
Procedures (Subcommittee on Exercise Testing).
J Am Coll Cardiol. 1986;8:725-38.
44.
Alpert JS, Chipkin SR, Aronin N. Diabetes mellitus
and silent myocardial ischemia. Adv Cardiol. 1990;37:279-303.
45.
Shindo T, Nosaka H, Kimura T, et al. Angiography
of silent myocardial ischemia. J Cardiol. 1991;21:761-9.
46.
Titus BG, Sherman CT. Asymptomatic myocardial
ischemia during percutaneous transluminal coronary
angioplasty and importance of prior Q-wave infarction
and diabetes mellitus. Am J Cardiol. 1991;68:735-9.
47.
Olivetti G, Melissari M, Capasso JM, Anversa P.
Cardiomyopathy of the aging human heart: myocyte
loss and reactive cellular hypertrophy. Circ Res.
1991;68:1560-8.
48.
GISSI-3: effects of lisinopril and transdermal
glyceryl trinitrate singly and together on 6-week
mortality and ventricular function after acute
myocardial infarction. Gruppo Italiano per lo
Studio della Sopravvivenza nell'infarto Miocardico.
Lancet. 1994;343:1115-22.
49.
Castelli WP. Epidemiology of coronary heart disease:
the Framingham study. Am J Med. 1984;76:4-12.
50.
Becker RC, Terrin M, Ross R, Knatterud GL, Desvigne-Nickens
P, Gore JM, Braunwald E, and the Thrombolysis
in Myocardial Infarction Investigators. Comparison
of clinical outcomes for women and men after acute
myocardial infarction. Ann Intern Med. 1994;120:638-45.
51.
Raby KE, Barry J, Creager MA, Cook EF, Weisberg
MC, Goldman L. Detection and significance of intraoperative
and postoperative myocardial ischemia in peripheral
vascular surgery. JAMA. 1992;268:222-7.
52.
Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard
JR. Cardiac assessment for patients undergoing
noncardiac surgery: a multifactorial clinical
risk index. Arch Intern Med. 1986;146:2131-4.
53.
The fifth report of the Joint National Committee
on Detection, Evaluation, and Treatment of High
Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-83.
54.
Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins
M, Shires GT. Preoperative characteristics predicting
intraoperative hypotension and hypertension among
hypertensives and diabetics undergoing noncardiac
surgery. Ann Surg. 1990;212:66-81.
55.
Stone JG, Foex P, Sear JW, Johnson LL, Khambatta
HJ, Triner L. Myocardial ischemia in untreated
hypertensive patients: effect of a single small
oral dose of a beta-adrenergic blocking agent.
Anesthesiology. 1988;68:495-500.
56.
Stone JG, Foex P, Sear JW, Johnson LL, Khambatta
HJ, Triner L. Risk of myocardial ischaemia during
anaesthesia in treated and untreated hypertensive
patients. Br J Anaesth. 1988;61:675-9.
57.
Prys-Roberts C, Meloche R, Foex P. Studies of
anaesthesia in relation to hypertension, I: cardiovascular
responses of treated and untreated patients. Br
J Anaesth. 1971;43:122-37.
58. Pasternack PF, Grossi EA,
Baumann FG, et al. Beta-blockade to decrease silent
myocardial ischemia during peripheral vascular
surgery. Am J Surg. 1989;158:113-6.
59.
Cucchiara RF, Benefiel DJ, Matteo RS, DeWood M,
Albin MS. Evaluation of esmolol in controlling
increases in heart rate and blood pressure during
endotracheal intubation in patients undergoing
carotid endarterectomy. Anesthesiology. 1986;65:528-31.
60.
Magnusson J, Thulin T, Werner O, Jarhult J, Thomson
D. Haemodynamic effects of pretreatment with metoprolol
in hypertensive patients undergoing surgery. Br
J Anaesth. 1986;58:251-60.
61.
Slogoff S, Keats AS. Does perioperative myocardial
ischemia lead to postoperative myocardial infarction?
Anesthesiology. 1985;62:107-14.
62.
Bedford RF, Feinstein B. Hospital admission blood
pressure: a predictor for hypertension following
endotracheal intubation. Anesth Analg. 1980;59:367-70.
63.
Goldman L, Caldera DL. Risks of general anesthesia
and elective operation in the hypertensive patient.
Anesthesiology. 1979;50:285-92.
64.
Thompson RC, Liberthson RR, Lowenstein E. Perioperative
anesthetic risk of noncardiac surgery in hypertrophic
obstructive cardiomyopathy. JAMA. 1985;254:2419-21.
65.
Reyes VP, Raju BS, Wynne J, et al. Percutaneous
balloon valvuloplasty compared with open surgical
commissurotomy for mitral stenosis. N Engl J Med.
1994;331:961-7.
66.
Stein PD, Alpert JS, Copeland J, Dalen JE, Goldman
S, Turpie AGG. Antithrombotic therapy in patients
with mechanical and biological prosthetic heart
valves. Chest. 1992;102(suppl):445S-55S.
67.
Goldman L, Caldera DL, Southwick FS, et al. Cardiac
risk factors and complications in non-cardiac
surgery. Medicine (Baltimore). 1978;57:357-70.
71.
Pastore JO, Yurchak PM, Janis KM, Murphy JD, Zir
LM. The risk of advanced heart block in surgical
patients with right bundle branch block and left
axis deviation. Circulation. 1978;57:677-80.
72.
Webb GD, Burrows FA. The risks of noncardiac surgery.
J Am Coll Cardiol. 1991;18:323-5.
73.
Lueker RD, Vogel JH, Blount SG Jr. Cardiovascular
abnormalities following surgery for left-to-right
shunts: observations in atrial septal defects,
ventricular septal defects, and patent ductus
arteriosus. Circulation. 1969;40:785-801.
74.
Maron BJ, Humphries JO, Rowe RD, Mellits ED. Prognosis
of surgically corrected coarctation of the aorta:
a 20-year postoperative appraisal. Circulation.
1973;47:119-26.
75.
James FW, Kaplan S, Schwartz DC, Chou TC, Sandker
MJ, Naylor V. Response to exercise in patients
after total surgical correction of tetralogy of
Fallot. Circulation. 1976;54:671-9.
76.
Neilson G, Galea EG, Blunt A. Eisenmenger's syndrome
and pregnancy. Med J Aust. 1971;1:431-434.
77.
Taylor LM Jr, Porter JM. Basic data related to
clinical decision-making in abdominal aortic aneurysms.
Ann Vasc Surg. 1987;1:502-4.
78.
Backer CL, Tinker JH, Robertson DM, Vlietstra
RE. Myocardial reinfarction following local anesthesia
for ophthalmic surgery. Anesth Analg. 1980;59:257-62.
79.
Warner MA, Shields SE, Chute CG. Major morbidity
and mortality within 1 month of ambulatory surgery
and anesthesia. JAMA. 1993;270:1437-41.
80.
Greenburg AG, Saik RP, Pridham D. Influence of
age on mortality of colon surgery. Am J Surg.
1985;150:65-70.
81.
Plecha FR, Bertin VJ, Plecha EJ, et al. The early
results of vascular surgery in patients 75 years
of age and older: an analysis of 3259 cases. J
Vasc Surg. 1985;2:769-74.
82.
Goldman L. Cardiac risks and complications of
noncardiac surgery. Ann Intern Med. 1983;98:504-13.
83.
Pedersen T, Eliasen K, Henriksen E. A prospective
study of risk factors and cardiopulmonary complications
associated with anaesthesia and surgery: risk
indicators of cardiopulmonary morbidity. Acta
Anaesthesiol Scand. 1990;34:144-55.
84.
Marsch SC, Schaefer HG, Skarvan K, Castelli I,
Scheidegger D. Perioperative myocardial ischemia
in patients undergoing elective hip arthroplasty
during lumbar regional anesthesia. Anesthesiology.
1992;76:518-27.
85.
Krupski WC, Layug EL, Reilly LM, Rapp JH, Mangano
DT. Comparison of cardiac morbidity rates between
aortic and infrainguinal operations: two-year
follow-up. Study of Perioperative Ischemia Research
Group. J Vasc Surg. 1993;18:609-15.
86.
L'Italien GJ, Cambria RP, Cutler BS, et al. Comparative
early and late cardiac morbidity among patients
requiring different vascular surgery procedures.
J Vasc Surg. 1995;21:935-44.
87.
Hsia DC, Krushat WM, Moscoe LM. Epidemiology of
carotid endarterectomies among Medicare beneficiaries.
J Vasc Surg. 1992;16:201-8.
88.
Fisher ES, Malenka DJ, Solomon NA, Bubolz TA,
Whaley FS, Wennberg JE. Risk of carotid endarterectomy
in the elderly. Am J Public Health. 1989;79:1617-20.
89.
Pilcher DB, Davis JH, Ashikaga T, et al. Treatment
of abdominal aortic aneurysm in an entire state
over 7 1/2 years. Am J Surg. 1980;139:487-94.
90.
Richardson JD, Main KA. Repair of abdominal aortic
aneurysms: a statewide experience. Arch Surg.
1991;126:614-6.
91.
Hannan EL, Kilburn H Jr, O'Donnell JF, et al.
A longitudinal analysis of the relationship between
in-hospital mortality in New York State and the
volume of abdominal aortic aneurysm surgeries
performed. Health Serv Res. 1992;27:517-42.
92.
Gillum RF. Peripheral arterial occlusive disease
of the extremities in the United States: hospitalization
and mortality. Am Heart J. 1990;120(pt 1):1414-8.
93.
Chassin MR, Park RE, Lohr KN, Keesey J, Brook
RH. Differences among hospitals in Medicare patient
mortality. Health Serv Res. 1989;24:1-31.
94.
Hobson RW II, Weiss DG, Fields WS, et al. Efficacy
of carotid endarterectomy for asymptomatic carotid
stenosis: The Veterans Affairs Cooperative Study
Group. N Engl J Med. 1993;328:221-7.
95.
Fleisher LA, Barash PG. Preoperative cardiac evaluation
for noncardiac surgery: a functional approach.
Anesth Analg. 1992;74:586-98.
96.
Fletcher JP, Antico VF, Gruenewald S, Kershaw
LZ. Risk of aortic aneurysm surgery as assessed
by preoperative gated heart pool scan. Br J Surg.
1989;76:26-8.
97.
Pedersen T, Kelbaek H, Munck O. Cardiopulmonary
complications in high-risk surgical patients:
the value of preoperative radionuclide cardiography.
Acta Anaesthesiol Scand. 1990;34:183-9.
98.
Lazor L, Russell JC, DaSilva J, Radford M. Use
of the multiple uptake gated acquisition scan
for the preoperative assessment of cardiac risk.
Surg Gynecol Obstet. 1988;167:234-8.
99.
Pasternack PF, Imparato AM, Bear G, et al. The
value of radionuclide angiography as a predictor
of perioperative myocardial infarction in patients
undergoing abdominal aortic aneurysm resection.
J Vasc Surg. 1984;1:320-5.
100.
Mosley JG, Clarke JM, Ell PJ, Marston A. Assessment
of myocardial function before aortic surgery by
radionuclide angiocardiography. Br J Surg. 1985;72:886-7.
101.
Pasternack PF, Imparato AM, Riles TS, et al. The
value of the radionuclide angiogram in the prediction
of perioperative myocardial infarction in patients
undergoing lower extremity revascularization procedures.
Circulation. 1985;72(suppl 2, pt 2):II-13-17.
102.
Kazmers A, Cerqueira MD, Zierler RE. The role
of preoperative radionuclide ejection fraction
in direct abdominal aortic aneurysm repair. J
Vasc Surg. 1988;8:128-36.
103.
Fiser WP, Thompson BW, Thompson AR, Eason C, Read
RC. Nuclear cardiac ejection fraction and cardiac
index in abdominal aortic surgery. Surgery. 1983;94:736-9.
104.
Hostetler MD, Dunn MI. Perioperative evaluation
of a patient with abdominal aortic aneurysm. JAMA.
1993;269:95.
105.
Poldermans D, Fioretti PM, Forster T, et al. Dobutamine
stress echocardiography for assessment of perioperative
cardiac risk in patients undergoing major vascular
surgery. Circulation. 1993;87:1506-12.
106.
McCabe CJ, Reidy NC, Abbott WM, Fulchino DM, Brewster
DC. The value of electrocardiogram monitoring
during treadmill testing for peripheral vascular
disease. Surgery. 1981;89:183-6.
107.
Cutler BS, Wheeler HB, Paraskos JA, Cardullo PA.
Applicability and interpretation of electrocardiographic
stress testing in patients with peripheral vascular
disease. Am J Surg. 1981;141:501-6.
108.
Arous EJ, Baum PL, Cutler BS. The ischemic exercise
test in patients with peripheral vascular disease:
implications for management. Arch Surg. 1984;119:780-3.
109.
Gardine RL, McBride K, Greenberg H, Mulcare RJ.
The value of cardiac monitoring during peripheral
arterial stress testing in the surgical management
of peripheral vascular disease. J Cardiovasc Surg
(Torino). 1985;26:258-61.
110.
von Knorring J, Lepantalo M. Prediction of perioperative
cardiac complications by electrocardiographic
monitoring during treadmill exercise testing before
peripheral vascular surgery. Surgery. 1986;99:610-3.
111.
Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos
JA, Cutler BS. Noninvasive evaluation of cardiac
risk before elective vascular surgery. J Am Coll
Cardiol. 1987;9:269-76.
112.
Hanson P, Pease M, Berkoff H, Turnipseed W, Detmer
D. Arm exercise testing for coronary artery disease
in patients with peripheral vascular disease.
Clin Cardiol. 1988;11:70-4.
113.
McPhail N, Calvin JE, Shariatmadar A, Barber GG,
Scobie TK. The use of preoperative exercise testing
to predict cardiac complications after arterial
reconstruction. J Vasc Surg. 1988;7:60-8.
114.
Carliner NH, Fisher ML, Plotnick GD, et al. Routine
preoperative exercise testing in patients undergoing
major noncardiac surgery. Am J Cardiol. 1985;56:51-8.
115.
Gerson MC, Hurst JM, Hertzberg VS, Baughman R,
Rouan GW, Ellis K. Prediction of cardiac and pulmonary
complications related to elective abdominal and
noncardiac thoracic surgery in geriatric patients.
Am J Med. 1990;88:101-7.
116.
Kopecky SL, Gibbons RJ, Hollier LH. Preoperative
supine exercise radionuclide angiogram predicts
perioperative cardiovascular events in vascular
surgery. J Am Coll Cardiol. 1986;7:226A. Abstract.
117.
Urbinati S, Di Pasquale G, Andreoli A, et al.
Preoperative noninvasive coronary risk stratification
in candidates for carotid endarterectomy. Stroke.
1994;25:2022-7.
118.
Chaitman BR. Exercise stress testing. In: Braunwald
E, ed. Heart Disease: A Textbook of Cardiovascular
Medicine. 4th ed. Philadelphia, Pa: WB Saunders
Co; 1992:168.
119.
Boucher CA, Brewster DC, Darling RC, Okada RD,
Strauss HW. Determination of cardiac risk by dipyridamole-thallium
imaging before peripheral vascular surgery. N
Engl J Med. 1985;312:389-94.
120.
Cutler BS, Leppo JA. Dipyridamole thallium 201
scintigraphy to detect coronary artery disease
before abdominal aortic surgery. J Vasc Surg.
1987;5:91-100.
121.
Fletcher JP, Antico VF, Gruenewald S, Kershaw
LZ. Dipyridamole-thallium scan for screening of
coronary artery disease prior to vascular surgery.
J Cardiovasc Surg (Torino). 1988;29:666-9.
122.
Sachs RN, Tellier P, Larmignat P, et al. Assessment
by dipyridamole-thallium-201 myocardial scintigraphy
of coronary risk before peripheral vascular surgery.
Surgery. 1988;103:584-7.
123.
McEnroe CS, O'Donnell RF Jr, Yeager A, Konstam
M, Mackey WC. Comparison of ejection fraction
and Goldman risk factor analysis of dipyridamole-thallium
201 studies in the evaluation of cardiac morbidity
after aortic aneurysm surgery. J Vasc Surg. 1990;11:497-504.
124.
Younis LT, Aguirre F, Byers S, et al. Perioperative
and long-term prognostic value of intravenous
dipyridamole thallium scintigraphy in patients
with peripheral vascular disease. Am Heart J.
1990;119:1287-92.
125.
Mangano DT, London MJ, Tubau JF, et al. Dipyridamole
thallium-201 scintigraphy as a preoperative screening
test: a reexamination of its predictive potential.
Study of Perioperative Ischemia Research Group.
Circulation. 1991;84:493-502.
126.
Strawn DJ, Guernsey JM. Dipyridamole thallium
scanning in the evaluation of coronary artery
disease in elective abdominal aortic surgery.
Arch Surg. 1991;126:880-4.
127.
Watters TA, Botvinick EH, Dae MW, et al. Comparison
of the findings on preoperative dipyridamole perfusion
scintigraphy and intraoperative transesophageal
echocardiography: implications regarding the identification
of myocardium at ischemic risk. J Am Coll Cardiol.
1991;18:93-100.
128.
Hendel RC, Whitfield SS, Villegas BJ, Cutler BS,
Leppo JA. Prediction of late cardiac events by
dipyridamole thallium imaging in patients undergoing
elective vascular surgery. Am J Cardiol. 1992;70:1243-9.
129.
Lette J, Waters D, Cerino M, Picard M, Champagne
P, Lapointe J. Preoperative coronary artery disease
risk stratification based on dipyridamole imaging
and a simple three-step, three-segment model for
patients undergoing noncardiac vascular surgery
or major general surgery. Am J Cardiol. 1992;69:1553-8.
130.
Madsen PV, Vissing M, Munck O, Kelbaek H. A comparison
of dipyridamole thallium 201 scintigraphy and
clinical examination in the determination of cardiac
risk before arterial reconstruction. Angiology.
1992;43:306-11.
131.
Brown KA, Rowen M. Extent of jeopardized viable
myocardium determined by myocardial perfusion
imaging best predicts perioperative cardiac events
in patients undergoing noncardiac surgery. J Am
Coll Cardiol. 1993;21:325-30.
132.
Kresowik TF, Bower TR, Garner SA, et al. Dipyridamole
thallium imaging in patients being considered
for vascular procedures. Arch Surg. 1993;128:299-302.
133.
Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium
scintigraphy and gated radionuclide angiography
to assess cardiac risk before abdominal aortic
surgery. N Engl J Med. 1994;330:663-9.
134.
Bry JD, Belkin M, O'Donnell TF Jr, et al. An assessment
of the positive predictive value and cost-effectiveness
of dipyridamole myocardial scintigraphy in patients
undergoing vascular surgery. J Vasc Surg. 1994;19:112-21.
135.
Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL,
Chaitman BR. Prognostic value of intravenous dipyridamole
thallium imaging in patients with diabetes mellitus
considered for renal transplantation. Am J Cardiol.
1990;65:1459-63.
136. Iqbal A, Gibbons RJ, McGoon
MD, Steiroff S, Frohnert PT, Velosa JA. Noninvasive
assessment of cardiac risk in insulin-dependent
diabetic patients being evaluated for pancreatic
transplantation using thallium-201 myocardial
perfusion scintigraphy. Transplant Proc. 1991;23(pt
2):1690-1.
137. Coley CM, Field TS, Abraham
SA, Boucher CA, Eagle KA. Usefulness of dipyridamole-thallium
scanning for preoperative evaluation of cardiac
risk for nonvascular surgery. Am J Cardiol. 1992;69:1280-5.
138.
Shaw L, Miller DD, Kong BA, et al. Determination
of perioperative cardiac risk by adenosine thallium-201
myocardial imaging. Am Heart J. 1992;124:861-9.
139.
Takase B, Younis LT, Byers SL, et al. Comparative
prognostic value of clinical risk indexes, resting
two-dimensional echocardiography, and dipyridamole
stress thallium-201 myocardial imaging for perioperative
cardiac events in major nonvascular surgery patients.
Am Heart J. 1993;126:1099-106.
140.
Younis L, Stratmann H, Takase B, Byers S, Chaitman
BR, Miller DD. Preoperative clinical assessment
and dipyridamole thallium-201 scintigraphy for
prediction and prevention of cardiac events in
patients having major noncardiovascular surgery
and known or suspected coronary artery disease.
Am J Cardiol. 1994;74:311-7.
141.
Ritchie JL, Bateman TM, Bonow RO, et al. Guidelines
for clinical use of cardiac radionuclide imaging:
a report of the American College of Cardiology/American
Heart Association Task Force on Assessment of
Diagnostic and Therapeutic Cardiovascular Procedures
(Committee on Radionuclide Imaging), developed
in collaboration with the American Society of
Nuclear Cardiology. J Am Coll Cardiol. 1995;25:521-47.
142.
Berthe C, Pierard LA, Hiernaux M, et al. Predicting
the extent and location of coronary artery disease
in acute myocardial infarction by echocardiography
during dobutamine infusion. Am J Cardiol. 1986;58:1167-72.
143.
Cohen JL, Greene TO, Ottenweller J, Binenbaum
SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography
for detecting coronary artery disease. Am J Cardiol.
1991;67:1311-8.
144.
Sawada SG, Segar DS, Ryan T, et al. Echocardiographic
detection of coronary artery disease during dobutamine
infusion. Circulation. 1991;83:1605-14.
145.
Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos
WR. Comparison of adenosine, dipyridamole, and
dobutamine in stress echocardiography. Ann Intern
Med. 1992;116:190-6.
146.
Marwick T, Willemart B, D'Hondt AM, et al. Selection
of the optimal nonexercise stress for the evaluation
of ischemic regional myocardial dysfunction and
malperfusion: comparison of dobutamine and adenosine
using echocardiography and 99mTc-MIBI single photon
emission computed tomography. Circulation. 1993;87:345-54.
147.
Lane RT, Sawada SG, Segar DS, et al. Dobutamine
stress echocardiography for assessment of cardiac
risk before noncardiac surgery. Am J Cardiol.
1991;68:976-7.
148.
Lalka SG, Sawada SG, Dalsing MC, et al. Dobutamine
stress echocardiography as a predictor of cardiac
events associated with aortic surgery. J Vasc
Surg. 1992;15:831-40.
149.
Eichelberger JP, Schwarz KQ, Black ER, Green RM,
Ouriel K. Predictive value of dobutamine echocardiography
just before noncardiac vascular surgery. Am J
Cardiol. 1993;72:602-7.
150.
Langan EM III, Youkey JR, Franklin DP, Elmore
JR, Costello JM, Nassef LA. Dobutamine stress
echocardiography for cardiac risk assessment before
aortic surgery. J Vasc Surg. 1993;18:905-11.
151.
Dávila-Román VG, Waggoner AD, Sicard GA, Geltman
EM, Schechtman KB, Perez JE. Dobutamine stress
echocardiography predicts surgical outcome in
patients with an aortic aneurysm and peripheral
vascular disease. J Am Coll Cardiol. 1993;21:957-63.
152.
DePuey EG, Guertler-Krawczynska E, Robbins WL.
Thallium-201 SPECT in coronary artery disease
patients with left bundle branch block. J Nucl
Med. 1988;29:1479-85.
153.
Larcos G, Gibbons RJ, Brown ML. Diagnostic accuracy
of exercise thallium-201 single-photon emission
computed tomography in patients with left bundle
branch block. Am J Cardiol. 1991;68:756-60.
154.
Rockett JF, Wood WC, Moinuddin M, Loveless V,
Parrish B. Intravenous dipyridamole thallium-201
SPECT imaging in patients with left bundle branch
block. Clin Nucl Med. 1990;15:401-7.
155.
O'Keefe JH Jr, Bateman TM, Barnhart CS. Adenosine
thallium-201 is superior to exercise thallium-201
for detecting coronary artery disease in patients
with left bundle branch block. J Am Coll Cardiol.
1993;21:1332-8.
156.
Hirzel HO, Senn M, Nuesch K, et al. Thallium-201
scintigraphy in complete left bundle branch block.
Am J Cardiol. 1984;53:764-9.
157.
Tighe DA, Hutchinson HG, Park CH, Chung EK, Fischman
DL, Raichlen JS. False-positive reversible perfusion
defect during dobutamine-thallium imaging in left
bundle branch block. J Nucl Med. 1994;35:1989-91.
158.
Fleisher LA, Rosenbaum SH, Nelson AH, Barash PG.
The predictive value of preoperative silent ischemia
for postoperative ischemic cardiac events in vascular
and nonvascular surgery patients. Am Heart J.
1991;122(pt 1):980-6.
159.
Kirwin JD, Ascer E, Gennaro M, et al. Silent myocardial
ischemia is not predictive of myocardial infarction
in peripheral vascular surgery patients. Ann Vasc
Surg. 1993;7:27-32.
160.
McPhail NV, Ruddy TD, Barber GG, Cole CW, Marois
LJ, Gulenchyn KY. Cardiac risk stratification
using dipyridamole myocardial perfusion imaging
and ambulatory ECG monitoring prior to vascular
surgery. Eur J Vasc Surg. 1993;7:151-5.
161.
Raby KE, Goldman L, Creager MA, et al. Correlation
between preoperative ischemia and major cardiac
events after peripheral vascular surgery. N Engl
J Med. 1989;321:1296-300.
162.
Pasternack PF, Grossi EA, Baumann FG, et al. The
value of silent myocardial ischemia monitoring
in the prediction of perioperative myocardial
infarction in patients undergoing peripheral vascular
surgery. J Vasc Surg. 1989;10:617-25.
163.
Fleisher LA, Rosenbaum SH, Nelson, Jain D, Wackers
FJT, Zaret BL. Preoperative dipyridamole thallium
imaging and Holter monitoring as a predictor of
perioperative cardiac events and long term outcome.
Anesthesiology. In press.
164.
Mantha S, Roizen MF, Barnard J, Thisted RA, Ellis
JE, Foss J. Relative effectiveness of four preoperative
tests for predicting adverse cardiac outcomes
after vascular surgery: a meta-analysis. Anesth
Analg. 1994;79:422-33.
166.
Rihal CS, Eagle KA, Mickel MC, Foster ED, Sopko
G, Gersh BJ. Surgical therapy for coronary artery
disease among patients with combined coronary
artery and peripheral vascular disease. Circulation.
1995;91:46-53.
167.
Coley CM, Eagle KA, Singer DE, et al. Decision
analysis for preoperative cardiac risk evaluation
before vascular surgery [abstr]. Clin Res. 1987;35:342A.
168.
Fleisher LA, Skolnick ED, Holroyd KJ, Lehmann
HP. Coronary artery revascularization before abdominal
aortic aneurysm surgery: a decision analytic approach.
Anesth Analg. 1994;79:661-9.
169.
Mason JJ, Owens DK, Harris RA, Cooke JP, Hlatky
MA. The role of coronary angiography and coronary
revascularization before noncardiac vascular surgery.
JAMA. 1995;273:1919-25.
170.
Diehl JT, Cali RF, Hertzer NR, Beven EG. Complications
of abdominal aortic reconstruction: an analysis
of perioperative risk factors in 557 patients.
Ann Surg. 1983;197:49-56.
171.
Crawford ES, Morris GC Jr, Howell JF, Flynn WF,
Moorhead DT. Operative risk in patients with previous
coronary artery bypass. Ann Thorac Surg. 1978;26:215-21.
172.
Reul GJ Jr, Cooley DA, Duncan JM, et al. The effect
of coronary bypass on the outcome of peripheral
vascular operations in 1093 patients. J Vasc Surg.
1986;3:788-98.
173.
Nielsen JL, Page CP, Mann C, Schwesinger WH, Fountain
RL, Grover FL. Risk of major elective operation
after myocardial revascularization. Am J Surg.
1992;164:423-6.
174. Hertzer NR, Beven EG, Young
JR, et al. Coronary artery disease in peripheral
vascular patients: a classification of 1000 coronary
angiograms and results of surgical management.
Ann Surg. 1984;199:223-33.
175.
Hertzer NR, Young JR, Beven EG, et al. Late results
of coronary bypass in patients with peripheral
vascular disease, I: five-year survival according
to age and clinical cardiac status. Cleve Clin
Q. 1986;53:133-143.
176.
European Coronary Surgery Study Group. Long-term
results of prospective randomised study of coronary
artery bypass surgery in stable angina pectoris.
Lancet. 1982;2:1173-80.
177.
Hertzer NR, Young JR, Beven EG, et al. Late results
of coronary bypass in patients with peripheral
vascular disease, II: five-year survival according
to sex, hypertension, and diabetes. Cleve Clin
J Med. 1987;54:15-23.
178.
Guidelines and indications for coronary artery
bypass graft surgery: a report of the American
College of Cardiology/American Heart Association
Task Force on Assessment of Diagnostic and Therapeutic
Cardiovascular Procedures (Subcommittee on Coronary
Artery Bypass Graft Surgery). J Am Coll Cardiol.
1991;17:543-89.
179.
Huber KC, Evans MA, Bresnahan JF, Gibbons RJ,
Holmes DR Jr. Outcome of noncardiac operations
in patients with severe coronary artery disease
successfully treated preoperatively with coronary
angioplasty. Mayo Clin Proc. 1992;67:15-21.
180.
Elmore JR, Hallett JW Jr, Gibbons RJ, et al. Myocardial
revascularization before abdominal aortic aneurysmorrhaphy:
effect of coronary angioplasty. Mayo Clin Proc.
1993;68:637-41.
181.
Allen JR, Helling TS, Hartzler GO. Operative procedures
not involving the heart after percutaneous transluminal
coronary angioplasty. Surg Gynecol Obstet. 1991;173:285-8.
183.
Coriat P, Daloz M, Bousseau D, Fusciardi J, Echter
E, Viars P. Prevention of intraoperative myocardial
ischemia during noncardiac surgery with intravenous
nitroglycerin. Anesthesiology. 1984;61:193-6.
184.
Dodds TM, Stone JG, Coromilas J, Weinberger M,
Levy DG. Prophylactic nitroglycerin infusion during
noncardiac surgery does not reduce perioperative
ischemia. Anesth Analg. 1993;76:705-13.
185.
Godet G, Coriat P, Baron JF, et al. Prevention
of intraoperative myocardial ischemia during noncardiac
surgery with intravenous diltiazem: a randomized
trial versus placebo. Anesthesiology. 1987;66:241-5.
186.
Pasternack PF, Imparato AM, Baumann FG, et al.
The hemodynamics of beta-blockade in patients
undergoing abdominal aortic aneurysm repair. Circulation.
1987;76(suppl 3, pt 2):III-1-7.
187.
Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS.
Palliative percutaneous aortic balloon valvuloplasty
before noncardiac operations and invasive diagnostic
procedures. Mayo Clin Proc. 1989;64:753-757.
188.
Rahimtoola SH. Catheter balloon valvuloplasty
of aortic and mitral stenosis in adults. Circulation.
1987;75:895-901.
189.
Marcus FI, Ewy GA, O'Rourke RA, Walsh B, Bleich
AC. The effect of pregnancy on the murmurs of
mitral and aortic regurgitation. Circulation.
1970;41:795-805.
190.
Waller TJ, Kay HR, Spielman SR, Kutalek SP, Greenspan
AM, Horowitz LN. Reduction in sudden death and
total mortality by antiarrhythmic therapy evaluated
by electrophysiologic drug testing: criteria of
efficacy in patients with sustained ventricular
tachyarrhythmia. J Am Coll Cardiol. 1987;10:83-9.
191.
Swerdlow CD, Winkle RA, Mason JW. Prognostic significance
of the number of induced ventricular complexes
during assessment of therapy for ventricular tachyarrhythmias.
Circulation. 1983;68:400-5.
192.
Guidelines for implantation of cardiac pacemakers
and antiarrhythmia devices: a report of the American
College of Cardiology/American Heart Association
Task Force on Assessment of Diagnostic and Therapeutic
Cardiovascular Procedures (Committee on Pacemaker
Implantation). J Am Coll Cardiol. 1991;18:1-13.
193.
Berlauk JF, Abrams JH, Gilmour IJ, O'Connor SR,
Knighton DR, Cerra FB. Preoperative optimization
of cardiovascular hemodynamics improves outcome
in peripheral vascular surgery: a prospective,
randomized clinical trial. Ann Surg. 1991;214:289-97.
195.
Verstraete M. The diagnosis and treatment of deep-vein
thrombosis. N Engl J Med. 1993;329:1418-20. Editorial
comment.
197.
Heijboer H, Cogo A, Buller HR, Prandoni P, ten
Cate JW. Detection of deep vein thrombosis with
impedance plethysmography and real-time compression
ultrasonography in hospitalized patients. Arch
Intern Med. 1992;152:1901-3.
198.
Moser KM, Fedullo PF. The diagnosis of deep vein
thrombosis. N Engl J Med. 1994;330:863-864. Letter.
199.
Bergqvist D, Jendteg S, Lindgren B, Matzsch T,
Persson U. The economics of general thromboembolic
prophylaxis. World J Surg. 1988;12:349-55.
200.
Criqui MH, Fronek A, Barrett-Connor E, Klauber
MR, Gabriel S, Goodman D. The prevalence of peripheral
arterial disease in a defined population. Circulation.
1985;71:510-5.
201.
Friedman SA, Pandya M, Greif E. Peripheral arterial
occlusion in patients with acute coronary heart
disease. Am Heart J. 1973;86:415-9.
202.
Cohen MM, Duncan PG, Tate RB. Does anesthesia
contribute to operative mortality? JAMA. 1988;260:2859-63.
203.
Leung JM, Goehner P, O'Kelly BF, et al. Isoflurane
anesthesia and myocardial ischemia: comparative
risk versus sufentanil anesthesia in patients
undergoing coronary artery bypass graft surgery.
The SPI (Study of Perioperative Ischemia) Research
Group. Anesthesiology. 1991;74:838-47.
204.
Baron JF, Bertrand M, Barre E, et al. Combined
epidural and general anesthesia versus general
anesthesia for abdominal aortic surgery. Anesthesiology.
1991;75:611-8.
205. Christopherson R, Beattie
C, Frank SM, et al. Perioperative morbidity in
patients randomized to epidural or general anesthesia
for lower extremity vascular surgery: Perioperative
Ischemia Randomized Anesthesia Trial Study Group.
Anesthesiology. 1993;79:422-34.
206.
Slogoff S, Keats AS. Randomized trial of primary
anesthetic agents on outcome of coronary artery
bypass operations. Anesthesiology. 1989;70:179-88.
207.
Tuman KJ, McCarthy RJ, Spiess BD. Epidural anaesthesia
and analgesia decreases postoperative hypercoagulability
in high-risk vascular patients. Anesth Analg.
1990;70:S414.
208.
Gallagher JD, Moore RA, Jose AB, Botros SB, Clark
DL. Prophylactic nitroglycerin infusions during
coronary artery bypass surgery. Anesthesiology.
1986;64:785-9.
209.
Thomson IR, Mutch WA, Culligan JD. Failure of
intravenous nitroglycerin to prevent intraoperative
myocardial ischemia during fentanyl-pancuronium
anesthesia. Anesthesiology. 1984;61:385-93.
210.
Eisenberg MJ, London MJ, Leung JM, et al. Monitoring
for myocardial ischemia during noncardiac surgery:
a technology assessment of transesophageal echocardiography
and 12-lead electrocardiography. The Study of
Perioperative Ischemia Research Group. JAMA. 1992;268:210-6.
211.
London MJ, Tubau JF, Wong MG, et al. The natural
history of segmental wall motion abnormalities
in patients undergoing noncardiac surgery: SPI
Research Group. Anesthesiology. 1990;73:644-55.
212.
Siu SC, Kowalchuk GJ, Welty FK, Benotti PN, Lewis
SM. Intra-aortic balloon counterpulsation support
in the high-risk cardiac patient undergoing urgent
noncardiac surgery. Chest. 1991;99:1342-5.
213.
Grotz RL, Yeston NS. Intra-aortic balloon counterpulsation
in high-risk cardiac patients undergoing noncardiac
surgery. Surgery. 1989;106:1-5.
214.
Mangano DT, Browner WS, Hollenberg M, Li J, Tateo
IM. Long-term cardiac prognosis following noncardiac
surgery: The Study of Perioperative Ischemia Research
Group. JAMA. 1992;268:233-9.
215.
Yeager RA, Moneta GL, Edwards JM, Taylor LM Jr,
McConnell DB, Porter JM. Late survival after perioperative
myocardial infarction complicating vascular surgery.
J Vasc Surg. 1994;20:598-606.
216.
Isaacson IJ, Lowdon JD, Berry AJ, et al. The value
of pulmonary artery and central venous monitoring
in patients undergoing abdominal aortic reconstructive
surgery: a comparative study of two selected,
randomized groups. J Vasc Surg. 1990;12:754-60.
217.
Joyce WP, Provan JL, Ameli FM, McEwan MM, Jelenich
S, Jones DP. The role of central haemodynamic
monitoring in abdominal aortic surgery: a prospective
randomised study. Eur J Vasc Surg. 1990;4:633-6.
218.
Practice guidelines for pulmonary artery catheterization:
a report by the American Society of Anesthesiologists
Task Force on Pulmonary Artery Catheterization.
Anesthesiology. 1993;78:380-94.
219.
Landesberg G, Luria MH, Cotev S, et al. Importance
of long-duration postoperative ST-segment depression
in cardiac morbidity after vascular surgery. Lancet.
1993;341:715-9.
220.
Fleisher LA, Nelson AH, Rosenbaum SH. Postoperative
myocardial ischemia: etiology of cardiac morbidity
or manifestation of underlying disease? J Clin
Anesth. 1995;7:97-102.
221.
Mathew JP, Fleisher LA, Rinehouse JA, et al. ST
segment depression during labor and delivery.
Anesthesiology. 1992;77:635-41.
222. Breslow MJ, Miller CF,
Parker SD, Walman AT, Rogers MC. Changes in T-wave
morphology following anesthesia and surgery: a
common recovery-room phenomenon. Anesthesiology.
1986;64:398-402.
223.
Adams JE III, Sicard GA, Allen BT, et al. Diagnosis
of perioperative myocardial infarction with measurement
of cardiac troponin I. N Engl J Med. 1994;330:670-4.
224.
Charlson ME, MacKenzie CR, Ales K, Gold JP, Fairclough
G Jr, Shires GT. Surveillance for postoperative
myocardial infarction after noncardiac operations.
Surg Gynecol Obstet. 1988;167:404-14.
225.
Rettke SR, Shub C, Naessens JM, Marsh HM, O'Brien
JF. Significance of mildly elevated creatine kinase
(myocardial band) activity after elective abdominal
aortic aneurysmectomy. J Cardio- thorac Vasc Anesth.
1991;5:425-30.
226.
Nordrehaug JE. Malignant arrhythmia in relation
to serum potassium in acute myocardial infarction.
Am J Cardiol. 1985;56:20D-3D.
227.
Hollifield JW. Thiazide treatment of systemic
hypertension: effects on serum magnesium and ventricular
ectopic activity. Am J Cardiol. 1989;63:22G-5G.
228.
Wong KC, Schafer PG, Schultz JR. Hypokalemia and
anesthetic implications. Anesth Analg. 1993;77:1238-60.
229. Deleted during update.
230.
Aronow WS, Ahn C. Incidence of heart failure in
2,737 older persons with and without diabetes
mellitus. Chest. 1999;115:867-8.
231. Shindler DM, Kostis JB,
Yusuf S, et al. Diabetes mellitus, a predictor
of morbidity and mortality in the Studies of Left
Ventricular Dysfunction (SOLVD) Trials and Registry.
Am J Cardiol. 1996;77:1017-20.
232.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A.
Continuous intravenous insulin infusion reduces
the incidence of deep sternal wound infection
in diabetic patients after cardiac surgical procedures.
Ann Thorac Surg. 1999;67:352-60.
233.
Pomposelli JJ, Baxter JK III, Babineau TJ, et
al. Early postoperative glucose control predicts
nosocomial infection rate in diabetic patients.
JPEN J Parenter Enteral Nutr. 1998;22:77-81.
234.
Samuels LE, Sharma S, Morris RJ, et al. Coronary
artery bypass grafting in patients with chronic
renal failure: a reappraisal. J Card Surg. 1996;11:128-33.
235. Corwin HL, Sprague SM,
DeLaria GA, Norusis MJ. Acute renal failure associated
with cardiac operations: a case-control study.
J Thorac Cardiovasc Surg. 1989;98:1107-12.
236.
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation
and prospective validation of a simple index for
prediction of cardiac risk of major noncardiac
surgery. Circulation. 1999;100:1043-49.
237.
Hogue CW Jr, Goodnough LT, Monk TG. Perioperative
myocardial ischemic episodes are related to hematocrit
level in patients undergoing radical prostatectomy.
Transfusion. 1998;38:924-31.
238.
Hahn RG, Nilsson A, Farahmand BY, Persson PG.
Blood haemoglobin and the long-term incidence
of acute myocardial infarction after transurethral
resection of the prostate. Eur Urol. 1997;31:199-203.
239.
Nelson AH, Fleisher LA, Rosenbaum SH. Relationship
between postoperative anemia and cardiac morbidity
in high-risk vascular patients in the intensive
care unit. Crit Care Med. 1993;21:860-6.
240.
O'Kelly B, Browner WS, Massie B, Tubau J, Ngo
L, Mangano DT. Ventricular arrhythmias in patients
undergoing noncardiac surgery: the Study of Perioperative
Ischemia Research Group. JAMA. 1992;268:217-21.
241.
Mahla E, Rotman B, Rehak P, et al. Perioperative
ventricular dysrhythmias in patients with structural
heart disease undergoing noncardiac surgery. Anesth
Analg. 1998;86:16-21.
242.
Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines
for perioperative cardiovascular evaluation for
noncardiac surgery: report of the American College
of Cardiology/American Heart Association Task
Force on Practice Guidelines (Committee on Perioperative
Cardiovascular Evaluation for Noncardiac Surgery).
J Am Coll Cardiol. 1996;27:910-48.
243.
Bartels C, Bechtel JF, Hossmann V, Horsch S. Cardiac
risk stratification for high-risk vascular surgery.
Circulation. 1997;95:2473-5.
244.
Glance LG. Selective preoperative cardiac screening
improves five-year survival in patients undergoing
major vascular surgery: a cost-effectiveness analysis.
J Cardiothorac Vasc Anesth. 1999;13:265-71.
245.
Rubin DN, Ballal RS, Marwick TH. Outcomes and
cost implications of a clinical-based algorithm
to guide the discriminate use of stress imaging
before noncardiac surgery. Am Heart J. 1997;134:83-92.
246.
Shaw LJ, Hachamovitch R, Cohen M, et al. Cost
implications of selective preoperative risk screening
in the care of candidates for peripheral vascular
operations. Am J Managed Care. 1997;3:1817-27.
247.
Reilly DF, McNeely MJ, Doerner D, et al. Self-reported
exercise tolerance and the risk of serious perioperative
complications. Arch Intern Med. 1999;159:2185-92.
248.
Older P, Hall A, Hader R. Cardiopulmonary exercise
testing as a screening test for perioperative
management of major surgery in the elderly. Chest.
1999;116:355-62.
249. Goldman L, Hashimoto B,
Cook EF, Loscalzo A. Comparative reproducibility
and validity of systems for assessing cardiovascular
functional class: advantages of a new specific
activity scale. Circulation. 1981;64:1227-34.
250.
Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Hjortholm
K, Andresen EB. Perioperative metoprolol reduces
the frequency of atrial fibrillation after thoracotomy
for lung resection. J Cardiothorac Vasc Anesth.
1997;11:746-51.
251.
Mangano DT, Layug EL, Wallace A, Tateo I. Effect
of atenolol on mortality and cardiovascular morbidity
after noncardiac surgery. Multicenter Study of
Perioperative Ischemia Research Group [published
erratum appears in N Engl J Med 1997;336:1039].
N Engl J Med. 1996;335:1713-20.
252.
Poldermans D, Boersma E, Bax JJ, et al, for the
Dutch Echocardiographic Cardiac Risk Evaluation
Applying Stress Echocardiography Study Group.
The effect of bisoprolol on perioperative mortality
and myocardial infarction in high-risk patients
undergoing vascular surgery. N Engl J Med. 1999;341:1789-94.
253.
Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat
P. The hemodynamic effects of anesthetic induction
in vascular surgical patients chronically treated
with angiotensin II receptor antagonists. Anesth
Analg. 1999;89:1388-92.
254.
Haering JM, Comunale ME, Parker RA, et al. Cardiac
risk of noncardiac surgery in patients with asymmetric
septal hypertrophy. Anesthesiology. 1996;85:254-9.
255.
Raymer K, Yang H. Patients with aortic stenosis:
cardiac complications in non-cardiac surgery.
Can J Anaesth. 1998;45:855-9.
256.
Torsher LC, Shub C, Rettke SR, Brown DL. Risk
of patients with severe aortic stenosis undergoing
noncardiac surgery. Am J Cardiol. 1998;81:448-52.
257.
Proceedings of the American College of Chest Physicians
5th Consensus on Antithrombotic Therapy. 1998.
Chest. 1998;114:439S-769S.
258.
ACC/AHA guidelines for the management of patients
with valvular heart disease: a report of the American
College of Cardiology/American Heart Association.
Task Force on Practice Guidelines (Committee on
Management of Patients with Valvular Heart Disease).
J Am Coll Cardiol. 1998;32:1486-588.
259.
Bayliff CD, Massel DR, Inculet RI, et al. Propranolol
| 
